交易 First Wave BioPharma, Inc. - FWBI CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
交易条件
价差 | 0.1520 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.024068% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.001846% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 0.001 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平倉 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
Mar 22, 2023 | 3.0193 | -0.0990 | -3.17% | 3.1183 | 3.1774 | 2.9687 |
Mar 21, 2023 | 3.1678 | 0.0892 | 2.90% | 3.0786 | 3.1678 | 3.0582 |
Mar 20, 2023 | 3.0588 | 0.0499 | 1.66% | 3.0089 | 3.1283 | 2.9691 |
Mar 17, 2023 | 3.0291 | 0.0600 | 2.02% | 2.9691 | 3.0391 | 2.9591 |
Mar 16, 2023 | 2.9695 | 0.1986 | 7.17% | 2.7709 | 3.0093 | 2.7704 |
Mar 15, 2023 | 2.9302 | 0.1883 | 6.87% | 2.7419 | 2.9302 | 2.6917 |
Mar 14, 2023 | 2.7715 | -0.1685 | -5.73% | 2.9400 | 2.9400 | 2.6912 |
Mar 13, 2023 | 3.0191 | -0.5440 | -15.27% | 3.5631 | 3.5731 | 2.9982 |
Mar 10, 2023 | 3.6238 | 0.0103 | 0.29% | 3.6135 | 3.6634 | 3.5640 |
Mar 9, 2023 | 3.7131 | -0.2472 | -6.24% | 3.9603 | 4.1786 | 3.5639 |
Mar 8, 2023 | 3.5246 | -0.0395 | -1.11% | 3.5641 | 3.6041 | 3.4648 |
Mar 7, 2023 | 3.5148 | -0.0593 | -1.66% | 3.5741 | 3.7130 | 3.5047 |
Mar 6, 2023 | 3.6437 | 0.0800 | 2.24% | 3.5637 | 3.7130 | 3.5637 |
Mar 3, 2023 | 3.6436 | 0.1790 | 5.17% | 3.4646 | 3.7723 | 3.4646 |
Mar 2, 2023 | 3.5146 | 0.0496 | 1.43% | 3.4650 | 3.5546 | 3.4650 |
Mar 1, 2023 | 3.5346 | 0.0200 | 0.57% | 3.5146 | 3.5645 | 3.4650 |
Feb 28, 2023 | 3.4750 | 0.1891 | 5.75% | 3.2859 | 3.5248 | 3.2856 |
Feb 27, 2023 | 3.4157 | -0.2371 | -6.49% | 3.6528 | 3.7229 | 3.3658 |
Feb 24, 2023 | 3.6733 | 0.0595 | 1.65% | 3.6138 | 3.7923 | 3.5241 |
Feb 23, 2023 | 3.7228 | -0.0391 | -1.04% | 3.7619 | 3.7924 | 3.6632 |
First Wave BioPharma, Inc. Events
時間(協調世界時) (UTC) | 國家 | 事件 |
---|---|---|
No events scheduled |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
总收入 | 0 | 0 | 0 | 0 | 0 |
总营业费用 | 59.0569 | 26.8313 | 14.7437 | 13.4318 | 10.2212 |
销售/一般/行政费用,总计 | 18.3696 | 7.27976 | 6.04227 | 8.17431 | 6.93171 |
研究与开发 | 38.3204 | 19.105 | 7.85849 | 4.98555 | 2.39548 |
Depreciation / Amortization | 0.015 | 0.048 | 0.84299 | 0.06191 | 0.754 |
Other Operating Expenses, Total | 0 | 0.21 | 0.14 | ||
营业收入 | -59.0569 | -26.8313 | -14.7437 | -13.4318 | -10.2212 |
利息收入(费用),非经营净值 | -0.01007 | -5.84013 | -0.43394 | -0.10185 | -0.8752 |
其他,净值 | 0.5291 | 0 | |||
税前净收入 | -58.5378 | -32.6715 | -15.1777 | -13.5336 | -11.0964 |
税后净收入 | -58.5378 | -32.6715 | -15.1777 | -13.5336 | -11.0964 |
未计算非常项目前的净收益 | -58.5378 | -32.6715 | -15.1777 | -13.5336 | -11.0964 |
净收入 | -58.5378 | -32.6715 | -15.1777 | -13.5336 | -11.0964 |
普通股股东可获收益 (不含非经常性项目) | -84.5186 | -41.7323 | -15.1777 | -13.5336 | -11.0964 |
普通股股东可获收益 (含非經常性項目) | -84.5186 | -41.7323 | -15.1777 | -13.5336 | -11.0964 |
摊薄净收入 | -84.5186 | -41.7323 | -15.1777 | -13.5336 | -11.0964 |
摊薄后加权平均股 | 8.92573 | 2.84363 | 2.24256 | 1.54393 | 1.06288 |
扣除特别项目的每股摊薄盈利 | -9.4691 | -14.6757 | -6.76803 | -8.76569 | -10.4399 |
每股正常摊薄盈利 | -9.20559 | -14.5356 | -6.76803 | -8.76569 | -10.4399 |
收入 | 0 | ||||
异常费用(收入) | 2.35199 | 0.39857 | |||
Total Adjustments to Net Income | -25.9807 | -9.06087 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
总收入 | 0 | 0 | 0 | 0 | 0 |
总营业费用 | 9.38207 | 11.167 | 30.3995 | 9.27689 | 8.21354 |
销售/一般/行政费用,总计 | 4.40556 | 3.03678 | 6.02116 | 3.62809 | 5.69751 |
研究与开发 | 4.97652 | 5.77821 | 24.3783 | 5.6468 | 2.51503 |
Depreciation / Amortization | 0.002 | 0.001 | |||
营业收入 | -9.38207 | -11.167 | -30.3995 | -9.27689 | -8.21354 |
利息收入(费用),非经营净值 | -0.00547 | -0.00123 | -0.00074 | -0.00295 | -0.00474 |
其他,净值 | -0.2393 | -0.00428 | -0.00057 | 0.0009 | 0.53265 |
税前净收入 | -9.62684 | -11.1725 | -30.4008 | -9.27894 | -7.68563 |
税后净收入 | -9.62684 | -11.1725 | -30.4008 | -9.27894 | -7.68563 |
未计算非常项目前的净收益 | -9.62684 | -11.1725 | -30.4008 | -9.27894 | -7.68563 |
净收入 | -9.62684 | -11.1725 | -30.4008 | -9.27894 | -7.68563 |
Total Adjustments to Net Income | -0.68577 | -0.11623 | -0.11809 | -3.45087 | -22.2956 |
普通股股东可获收益 (不含非经常性项目) | -10.3126 | -11.2887 | -30.5189 | -12.7298 | -29.9812 |
普通股股东可获收益 (含非經常性項目) | -10.3126 | -11.2887 | -30.5189 | -12.7298 | -29.9812 |
摊薄净收入 | -10.3126 | -11.2887 | -30.5189 | -12.7298 | -29.9812 |
摊薄后加权平均股 | 15.5447 | 12.9223 | 9.34236 | 7.81244 | 5.53481 |
扣除特别项目的每股摊薄盈利 | -0.66342 | -0.87359 | -3.26672 | -1.62943 | -5.41684 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | -0.66342 | -0.69158 | -3.26672 | -1.62943 | -5.41684 |
异常费用(收入) | 2.35199 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
流动资产总额 | 9.42495 | 7.86978 | 3.40829 | 4.8 | 1.95257 |
现金和短期投资 | 8.24868 | 6.06214 | 0.1758 | 1.11434 | 0.57347 |
Cash | 8.24868 | 6.06214 | 0.1758 | 1.11434 | 0.57347 |
短期投资 | |||||
应收账款总额,净额 | 0 | 0.55149 | 2.6373 | 3.17268 | 1.10413 |
Prepaid Expenses | 1.17627 | 1.25615 | 0.59519 | 0.51298 | 0.27496 |
Total Assets | 11.79 | 12.9239 | 8.90288 | 7.4694 | 5.47967 |
Property/Plant/Equipment, Total - Net | 0.40931 | 0.09257 | 0.15978 | 0.12885 | 0.13399 |
Goodwill, Net | 1.91171 | 2.05405 | 1.88669 | 1.92483 | 2.01624 |
Intangibles, Net | 0 | 2.87954 | 3.40708 | 0.57048 | 1.34596 |
Other Long Term Assets, Total | 0.04401 | 0.02792 | 0.04105 | 0.04523 | 0.03092 |
Total Current Liabilities | 12.3004 | 15.5454 | 4.28564 | 2.99552 | 2.47908 |
Payable/Accrued | 0 | 0.53343 | 0.6701 | 2.05534 | |
Accrued Expenses | 0.49706 | 0.18443 | 0.15441 | 0.53829 | 0.00719 |
Notes Payable/Short Term Debt | 0.64124 | 0.55241 | 1.5213 | 0.25503 | 0.41655 |
Other Current Liabilities, Total | 8.48018 | 13.25 | 0.39299 | ||
Total Liabilities | 19.6115 | 15.5646 | 4.28564 | 2.99552 | 3.81908 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 7.31114 | 0.01912 | 0 | 0 | 1.34 |
Total Equity | -7.82155 | -2.64069 | 4.61724 | 4.47387 | 1.66059 |
Common Stock | 0.00149 | 0.00312 | 0.00268 | 0.00177 | 0.00121 |
Additional Paid-In Capital | 147.305 | 93.8349 | 68.5759 | 53.1393 | 37.6696 |
Retained Earnings (Accumulated Deficit) | -153.904 | -95.3662 | -62.6947 | -47.5171 | -33.9834 |
Other Equity, Total | -1.22414 | -1.11255 | -1.26656 | -1.15011 | -2.02679 |
Total Liabilities & Shareholders’ Equity | 11.79 | 12.9239 | 8.90288 | 7.4694 | 5.47967 |
Total Common Shares Outstanding | 14.8559 | 3.11503 | 2.68005 | 1.77049 | 1.20426 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Property/Plant/Equipment, Total - Gross | 0.42402 | 0.13097 | 0.4233 | 0.33225 | |
Accumulated Depreciation, Total | -0.01471 | -0.0384 | -0.26352 | -0.20339 | |
Accounts Payable | 2.68191 | 1.55859 | 1.68351 | 1.53211 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
流动资产总额 | 6.55017 | 9.42495 | 7.50249 | 8.61528 | 13.1704 |
现金和短期投资 | 5.69499 | 8.24868 | 7.21065 | 8.07449 | 12.0256 |
Cash | 5.69499 | 8.24868 | 7.21065 | 8.07449 | 12.0256 |
应收账款总额,净额 | 0.02806 | 0 | 0 | 0 | 0.50166 |
Prepaid Expenses | 0.82713 | 1.17627 | 0.29184 | 0.54079 | 0.64313 |
Total Assets | 8.82544 | 11.79 | 12.424 | 13.7768 | 17.9829 |
Property/Plant/Equipment, Total - Net | 0.3788 | 0.40931 | 0.44889 | 0.48488 | 0.06162 |
Property/Plant/Equipment, Total - Gross | 0.40083 | 0.42402 | 0.45632 | 0.4861 | 0.0812 |
Accumulated Depreciation, Total | -0.02203 | -0.01471 | -0.00743 | -0.00123 | -0.01958 |
Goodwill, Net | 1.86207 | 1.91171 | 1.94474 | 1.99129 | 1.97396 |
Intangibles, Net | 0 | 2.48388 | 2.61576 | 2.74765 | |
Other Long Term Assets, Total | 0.0344 | 0.04401 | 0.04403 | 0.0696 | 0.02924 |
Total Current Liabilities | 14.2157 | 12.3004 | 19.0983 | 6.45412 | 3.57464 |
Accounts Payable | 3.44993 | 2.68191 | 18.4478 | 4.44991 | 1.44072 |
Accrued Expenses | 0.7883 | 0.49706 | 0.22987 | 0.31246 | 0.32383 |
Notes Payable/Short Term Debt | 0.40277 | 0.64124 | 0 | 0.13957 | 0.34708 |
Other Current Liabilities, Total | 9.57473 | 8.48018 | 0.42063 | 1.55218 | 1.46302 |
Total Liabilities | 18.0652 | 19.6115 | 19.394 | 6.73988 | 3.58121 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 3.8495 | 7.31114 | 0.29569 | 0.28575 | 0.00657 |
Total Equity | -9.23979 | -7.82155 | -6.96999 | 7.03692 | 14.4017 |
Common Stock | 0.00215 | 0.00149 | 0.00111 | 0.00826 | 0.00749 |
Additional Paid-In Capital | 155.571 | 147.305 | 137.028 | 120.585 | 118.693 |
Retained Earnings (Accumulated Deficit) | -163.531 | -153.904 | -142.732 | -112.331 | -103.052 |
Other Equity, Total | -1.28254 | -1.22414 | -1.26711 | -1.2255 | -1.24734 |
Total Liabilities & Shareholders’ Equity | 8.82544 | 11.79 | 12.424 | 13.7768 | 17.9829 |
Total Common Shares Outstanding | 21.5488 | 14.8559 | 11.1152 | 8.25851 | 7.49269 |
Preferred Stock - Non Redeemable, Net | 0 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
净收入/起跑线 | -58.5378 | -32.6715 | -15.1777 | -13.5336 | -11.0964 |
经营活动产生的现金 | -32.2882 | -11.2215 | -14.0335 | -10.8693 | -7.18464 |
经营活动产生的现金 | 0.01471 | 0.0378 | 0.0631 | 0.06191 | 0.04952 |
Amortization | 0.52755 | 0.52755 | 0.95695 | 0.73654 | 0.70448 |
非现金物品 | 8.60641 | 6.73365 | 1.82513 | 3.57765 | 3.42595 |
营运资金的变化 | 17.101 | 14.1509 | -1.70099 | -1.7118 | -0.26821 |
投资活动产生的现金 | -10.3195 | 0.08735 | -0.0241 | -0.30547 | -0.03217 |
资本支出 | -0.06949 | -0.00417 | -0.0241 | -0.30547 | -0.03217 |
融资活动产生的现金 | 44.7635 | 17.0461 | 13.145 | 11.7121 | 6.01322 |
融资现金流项目 | 0 | ||||
股票的发行(报废),净额 | 44.6747 | 14.1861 | 9.53834 | 11.9028 | 5.00923 |
债务的发行(退还),净额 | 0.08883 | 2.86003 | 3.60664 | -0.19068 | 1.00399 |
外汇效应 | 0.03076 | -0.02559 | -0.02593 | 0.00354 | 0.00353 |
现金净变化 | 2.18654 | 5.88635 | -0.93855 | 0.54087 | -1.20005 |
Cash Taxes Paid | 0 | 0 | 0 | 0 | |
已付现金利息 | 0 | 0.10546 | 0.00803 | 0.00401 | 0.00415 |
其他投资现金流量项目,总计 | -10.25 | 0.09152 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -9.62684 | -58.5378 | -47.3654 | -16.9646 | -7.68563 |
Cash From Operating Activities | -7.91207 | -32.2882 | -26.4254 | -10.6961 | -5.07339 |
Cash From Operating Activities | 0.00732 | 0.01471 | 0.00939 | 0.00301 | 0.00102 |
Amortization | 0 | 0.52755 | 0.39566 | 0.26377 | 0.13189 |
Non-Cash Items | 0.36042 | 8.60641 | 2.04186 | 1.7359 | 1.80638 |
Cash Interest Paid | 0 | 0 | 0 | 0 | 0.00514 |
Changes in Working Capital | 1.34703 | 17.101 | 18.493 | 4.26576 | 0.67294 |
Cash From Investing Activities | -10.3195 | -10.3215 | -9.07393 | 0 | |
Capital Expenditures | -0.06949 | -0.07145 | -0.07393 | 0 | |
Cash From Financing Activities | 5.36715 | 44.7635 | 37.9406 | 21.8326 | 11.0506 |
Financing Cash Flow Items | -2.41496 | -9.53235 | |||
Issuance (Retirement) of Stock, Net | 8.02057 | 44.6747 | 38.493 | 22.2454 | 20.7883 |
Issuance (Retirement) of Debt, Net | -0.23847 | 0.08883 | -0.55241 | -0.41284 | -0.20532 |
Foreign Exchange Effects | -0.00877 | 0.03076 | -0.04525 | -0.05019 | -0.01374 |
Net Change in Cash | -2.5537 | 2.18654 | 1.1485 | 2.01235 | 5.96349 |
Cash Taxes Paid | 0 | 0 | 0 | ||
Other Investing Cash Flow Items, Total | -10.25 | -10.25 | -9 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
Sapirstein (James E) | Individual Investor | 4.3072 | 42857 | 42857 | 2023-01-03 | HIGH |
Armistice Capital LLC | Hedge Fund | 4.2206 | 41995 | 41995 | 2022-12-31 | HIGH |
Romano (Sarah M.) | Individual Investor | 2.1537 | 21429 | 21429 | 2023-01-03 | MED |
Hoffman (David Andrew) | Individual Investor | 1.3033 | 12968 | 12106 | 2023-01-03 | HIGH |
Borkowski (Edward J) | Individual Investor | 1.237 | 12308 | 12106 | 2023-01-03 | |
Riddell (Alastair) | Individual Investor | 1.223 | 12169 | 12106 | 2023-01-03 | |
Casamento (Charles J) | Individual Investor | 1.2223 | 12162 | 12106 | 2023-01-03 | |
Coelho (Mary Theresa) | Individual Investor | 1.2167 | 12106 | 12106 | 2023-01-03 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 1.1858 | 11799 | 0 | 2022-12-31 | LOW |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 0.7214 | 7178 | 7178 | 2022-12-31 | MED |
Susquehanna International Group, LLP | Investment Advisor | 0.2193 | 2182 | 2182 | 2022-12-31 | MED |
UBS Financial Services, Inc. | Investment Advisor | 0.2048 | 2038 | 1752 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.1537 | 1529 | 1529 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 0.0982 | 977 | 0 | 2023-02-28 | LOW |
Tower Research Capital LLC | Hedge Fund | 0.0975 | 970 | 497 | 2022-12-31 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.0379 | 377 | 0 | 2022-12-31 | LOW |
Advisor Group, Inc | Investment Advisor | 0.0287 | 286 | 286 | 2022-12-31 | LOW |
Wells Fargo Advisors | Research Firm | 0.0027 | 27 | 0 | 2022-12-31 | LOW |
U.S. Bancorp Asset Management, Inc. | Investment Advisor | 0.0024 | 24 | 0 | 2022-12-31 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.0022 | 22 | 0 | 2022-12-31 | LOW |
交易計算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
貿易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
開倉
平倉
做空 做多
First Wave BioPharma, Inc. Company profile
关于 First Wave BioPharma Inc.
第一波生物制药公司,前身是AzurRx生物制药公司,是一家临床阶段的生物制药公司。 它从事胃肠道(GI)疾病的靶向、非系统疗法的开发。 该公司专注于推进围绕其两项技术建立的治疗开发管道:尼可刹米,一种具有抗病毒和抗炎特性的口服小分子,以及生物制剂adrulipase,一种重组脂肪酶,旨在使脂肪和其他营养物质得到消化。 公司的烟酰胺产品组合由三个临床项目主导。 FW-COV,治疗COVID-19胃肠道感染;FW-UP,治疗溃疡性直肠炎(UP)和溃疡性直肠乙状结肠炎;FW-ICI-AC,治疗晚期肿瘤患者的1级和2级免疫检查点抑制剂相关的结肠炎和腹泻。 该公司还在推进FW-EPI(阿曲酶),用于治疗囊性纤维化和慢性胰腺炎患者的外分泌胰腺功能不全(EPI)。
Industry: | Biotechnology & Medical Research (NEC) |
777 Yamato Road
Suite 502
BOCA RATON
FLORIDA 33431
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。